WASHINGTON (AP) — Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it's far from clear how well the technology works. Grail Inc.’s Galleri test doesn't diagnose cancer but instead, with a single blood draw, looks for a signal that someone [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA panel endorses first-of-a-kind cancer blood test from Grail | 0 | 8.41 | 23-09-2026 |
| 2 | FDA panel endorses first-of-a-kind cancer blood test from Grail | 0 | 8.41 | 23-09-2026 |
| 3 | Blood test finds hidden pancreatic cancer after treatment | 5 | 8 | 30-06-2026 |
| 4 | A single blood test could spot multiple cancers early, saving lives | 0 | 9.73 | 16-02-2026 |
| 5 | В Москве представили инновационный тест для раннего обнаружения рака | 0 | 0 | 02-10-2025 |
| 6 | Ultrasensitive blood test predicts head and neck cancer relapse months earlier | 5 | 7 | 10-06-2026 |
| 7 | Blood test shows promise for detecting pancreatic cancer at its earliest stages | 0 | 5.07 | 16-09-2026 |
| 8 | New blood test for noncoding RNA significantly improves cancer detection | 7 | 8 | 31-08-2023 |
| 9 | New blood test shows superior sensitivity in detecting HPV-associated head and neck cancers | 7 | 8 | 20-05-2025 |